CA
DXCM icon

Crewe Advisors’s DexCom DXCM Stock Holding History

Crewe Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.44K Buy
51
+21
+70% +$1.4K ﹤0.01% 935
2026
Q1 		$1.88K Buy
30
+23
+329% +$1.6K ﹤0.01% 910
2025
Q4 		$465 Buy
+7
New +$453 ﹤0.01% 1047
2025
Q3 		– Sell
-5
Closed -$437 – 984
2025
Q2 		$437 Buy
+5
New +$392 ﹤0.01% 654
2024
Q4 		– Sell
-203
Closed -$13.6K – 687
2024
Q3 		$13.6K Hold
203
– – ﹤0.01% 447
2024
Q2 		$23K Sell
203
-7
-3% -$885 ﹤0.01% 528
2024
Q1 		$29.1K Buy
+210
New +$26.4K ﹤0.01% 439
2023
Q3 		– Sell
-37
Closed -$4.75K – 680
2023
Q2 		$4.75K Sell
37
-182
-83% -$22K ﹤0.01% 471
2023
Q1 		$25.4K Sell
219
-62
-22% -$6.94K ﹤0.01% 384
2022
Q4 		$31.8K Sell
281
-95
-25% -$10.4K 0.01% 353
2022
Q3 		$30K Buy
376
+28
+8% +$2.37K 0.01% 389
2022
Q2 		$26K Buy
+348
New +$31.8K 0.01% 375
2021
Q4 		– Sell
-16
Closed -$2K – 417
2021
Q3 		$2K Hold
16
– – ﹤0.01% 352
2021
Q2 		$2K Hold
16
– – ﹤0.01% 398
2021
Q1 		$1K Hold
16
– – ﹤0.01% 434
2020
Q4 		$1K Sell
16
-12
-43% -$1.07K ﹤0.01% 423
2020
Q3 		$3K Buy
+28
New +$2.92K ﹤0.01% 437

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Crewe Advisors's DXCM Position: Q2 2026 in Review

Crewe Advisors increased its DexCom (DXCM) stake by 70% in Q2 2026, buying an estimated $1.4K and bringing the position to 51 shares worth $3.44K. The position accounts for ﹤0.01% of the portfolio, ranked #935.

Crewe Advisors first reported a position in DXCM in Q3 2020 and has held it in 17 quarters since. The position peaked at $31.8K in Q4 2022. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Crewe Advisors held 51 shares of DexCom worth $3.44K as of Q2 2026.
  • Crewe Advisors bought 21 DexCom shares in Q2 2026, an estimated $1.4K.
  • DexCom made up ﹤0.01% of Crewe Advisors's portfolio in Q2 2026, its #935 holding.
  • Crewe Advisors first reported a position in DexCom in Q3 2020 and has held it in 17 quarters since.
  • Crewe Advisors's DexCom position peaked at $31.8K in Q4 2022.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.